Het ontrafelen van hypofyse stamcelactivatie na lokale schade en het verdwijnen ervan bij veroudering
Year: 2022
Type: dissertation
Abstract: The pituitary constitutes, together with the hypothalamus, the core of our endocrine system. Through meticulous secretion of hormones, the pituitary controls other endocrine glands, thereby regulating essential physiological processes such as growth, metabolism, sexual development and stress response. Because of this key role, correct functioning of the pituitary is essential. The anterior pituitary (AP), which represents the main hormone-producing lobe of the gland, has been demonstrated to house a population of stem cells, marked by SOX2 expression. The stem cells were found to be involved in pituitary homeostatic turnover and in cell adaptation to endocrine demands, although contributions were very modest, with the stem cells being mainly dormant. In contrast, following local injury in young mice (as inflicted by transgenic endocrine cell ablation), SOX2+ stem cells are promptly activated, and the destroyed endocrine cells are substantially regenerated after 4-5 months. Intriguingly, regeneration is no longer observed in middle-aged mice, coinciding with a decrease in stem cell number. At the start of our study, virtually nothing was known about the mechanisms behind injury-induced pituitary stem cell activation and its waning at aging. Therefore, this thesis aimed at acquiring more insight into the mechanisms driving the quiescent pituitary stem cells into activation upon local damage, and into the changes occurring in the aging pituitary impacting the stem cells' reaction to injury and their functionality. First, we compared the pituitary stem cell reaction to endocrine cell-ablation injury in young and aging (middle-aged) mice. The acute proliferative response of the stem cells to damage in the young AP was found to subside with aging. In addition, organoid culturing, an in vitro readout tool of pituitary stem cell functionality and activation, showed lower organoid formation efficiency from aging AP, both in basal (undamaged) and damaged conditions, thereby reflecting and supporting decreased number and lower activatability of stem cells in the aging gland. Second, we applied single-cell transcriptome profiling to unravel molecular mechanisms underlying injury-induced pituitary stem cell activation and its fading at aging. We observed that injury triggers an inflammatory response in the young pituitary, thereby particularly uncovering the cytokine interleukin 6 (IL-6) as highly upregulated, mainly in the stem and connective tissue (CT) cell clusters. We found that the cytokine stimulated organoid formation (and serial passaging) from undamaged young AP, and that blocking IL-6 downstream signaling in organoid cultures of damaged young AP inhibited organoid growth, both indicating a stem cell-activating nature of IL-6. Administration of the cytokine to young mice resulted in an acute proliferative response of the pituitary SOX2+ stem cells, while blocking IL-6 or its downstream signaling prevented the proliferative stem cell reaction to injury, thus corroborating its pituitary stem cell-activating property. Intriguingly, treatment of aging mice with IL-6 did not evoke a pituitary stem cell activation response. Comparing the single-cell transcriptomes of young and aging (undamaged) AP uncovered an elevated inflammatory phenotype and higher IL-6 levels in the aging AP - pointing to the appealing concept of inflammaging -, that could underlie the age difference in stem cell reaction to injury. Intriguingly, when cultured in organoid conditions, the aging pituitary stem cells regained their sensitivity to IL-6 and showed equally efficient organoid passaging than young pituitary stem cells, indicating that aging stem cells regained functionality when liberated from their in vivo (micro-)environment. The observation indicates that aging pituitary stem cells are intrinsically not impacted but that their functionality is impeded by the (inflamm-)aging milieu. Taken together, we discovered IL-6 as a pituitary stem cell activator contributing to the stem cell response to local injury in young pituitary, however quenching in the aging gland because of a prevailing local inflammatory setting. Our findings may pave the way toward regenerative as well as rejuvenative strategies to counteract pituitary functional decline as occurring upon disease, trauma or aging.
Source: Lirias
Author: Vennekens, Annelies
Institution: KU Leuven
Language: English
Subfield: Developmental Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Pituitary regeneration and aging: role of the pituitary stem cells and Hippo pathway, Illuminating the black box of pituitary stem cell activation: spotlights on interleukin-6., G2415059240, Pituitary deficiency and regeneration: in search of underlying mechanisms and therapeutic targets with focus on Wnt/Lgr5, Uncovering the epigenetic landscape of cell fate reprogramming and pluripotency, G6809982507, Pituitary remodeling during tumorigenesis and regeneration: functional position of the WNT pathway and pituitary stem cells
OpenAlex ID: W7048065363
